JPX : 4595.T

Mizuho Medy Co.,Ltd.

$1655 JPY

-$22 (-1.31%)

Volume
99.6K
Average Volume
103.08K
Market Capitalization
$31.53B
P/E Ratio
9.70
Dividend Yield
6.04%
Price Target
Year High
$1930.00
Year Low
$1424.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$11.59
Company Overview

JPX

Fuminari Karakawa

Drug Manufacturers - Specialty & Generic

Healthcare

4595.T

193

JP

JPY

81 9 4285 0303

N/A

N/A

Liquidity Metrics

0.00

11.59

9.80

8.00

0.00

Sales & Valuation

$11.26B

2.91

1.72

0.00

0.00

Profitability

$179.8

$3.42B

30.03%

41.55%

18.28%

15.52%

P/E Metrics

9.70

-1.05

-1.05

Analyst Price Target & Rating

Buy

4/5

0 Analysts

%

Financial Health Scores

10.70

4/9

$16.6B

$20.93B

$2.6B

$4.28B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Kenji Narahara Head of Development & Planning and Director
Toshio Kamihara GM of Sales Division & Overseas Business Department and Director
Takahiro Furuno Executive Officer & Manager of Manufacturing Department
Fuminari Karakawa Chairman of the Board & President
Kazuhiro Ichimaru GM of Intellectual Property & Manufacturing Department and Director
Poll Results

No votes yet today — be the first to share your view!

About Mizuho Medy Co.,Ltd. (JPX:4595.T) Stock

Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd. specializes in the research, development, production, and distribution of in-vitro diagnostic solutions, complemented by scientific and technical information services. While its primary operations are in Japan, the company maintains an international presence through import and export activities, extending its reach to countries including the United States, Belgium, Finland, the Netherlands, Taiwan, and Thailand. Its extensive product lineup includes a wide array of immunoassay test kits designed for detecting pathogens such as influenza viruses, RS virus, human metapneumovirus, Streptococcus pneumoniae, Legionella, Mycoplasma pneumoniae, adenovirus, rotavirus, norovirus, and Group A streptococcus. Additionally, Mizu ... ho Medy offers kits for pregnancy, ovulation, and fecal occult blood screening. The company also provides advanced tools like gene analysis instruments and specialized diagnostic kits for SARS-CoV-2 detection and Mycoplasma pneumoniae nucleic acid analysis.

Frequently Asked Questions

What is the current Mizuho Medy Co.,Ltd. (4595.T) stock price?

Mizuho Medy Co.,Ltd.(JPX:4595.T) stock price is $1655 in the last trading session. During the trading session, 4595.T stock reached the peak price of $1930 while $1424 was the lowest point it dropped to. The percentage change in 4595.T stock occurred in the recent session was --1.31% while the dollar amount for the price change in 4595.T stock was -$22.

4595.T's industry and sector of operation?

The JPX listed 4595.T is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of 4595.T?

Kenji Narahara | Head of Development & Planning and Director
Toshio Kamihara | GM of Sales Division & Overseas Business Department and Director
Takahiro Furuno | Executive Officer & Manager of Manufacturing Department
Fuminari Karakawa | Chairman of the Board & President
Kazuhiro Ichimaru | GM of Intellectual Property & Manufacturing Department and Director

How many employees does 4595.T have?

Number of 4595.T employees currently stands at 193. 4595.T operates from 5-4 Fujinoki-machi, Tosu, SA 841-0048, JP.

Link for 4595.T official website?

Official Website of 4595.T is: https://www.mizuho-m.co.jp

How do I contact 4595.T?

4595.T could be contacted at phone #81 9 4285 0303 and can also be accessed through its website. 4595.T operates from 5-4 Fujinoki-machi, Tosu, SA 841-0048, JP.

How many shares of 4595.T are traded daily?

The average number of 4595.T shares traded daily for last 3 months was 103.08K.

What is the market cap of 4595.T currently?

The market value of 4595.T currently stands at $31.53B with its latest stock price at $1655